The National Institute for Biotechnology in the Negev (NIBN) was established in 2009 under the auspices of Ben-Gurion University of the Negev as a pioneering translational research framework dedicated to advancing high-potential biomedical and biotechnological innovation.
The institute was created to address a structural gap within the academic system: the challenge of transforming outstanding scientific research into viable technologies, development programs, and real-world solutions. Positioned on Ben-Gurion University of the Negev’s main campus in Be’er-Sheva, NIBN was designed as an integrated environment where scientific excellence, development thinking, and commercialization-oriented execution converge.
From its foundation, NIBN was structured to operate beyond traditional academic boundaries, focusing on the advancement of ambitious, high-risk, high-impact research programs with clear potential for application in medicine, life sciences, and biotechnology.
Mission and Strategic Direction
NIBN was founded with a clear and focused mission: to accelerate the translation of scientific discoveries into impactful biotechnological solutions.
The framework emphasizes research driven not only by scientific curiosity, but also by its potential to address real unmet needs and evolve into meaningful therapeutic, diagnostic, and technological solutions. Projects are shaped around development feasibility, technological maturity, and structured progression pathways, rather than purely academic endpoints.
By integrating scientific leadership with development-oriented thinking, NIBN creates an environment in which ideas are challenged, refined, and advanced with a constant focus on applicability, scalability, and impact.
A Unique Organizational Model
NIBN was established as a distinct organizational model within the Israeli academic landscape. Unlike conventional research centers, the institute was designed to function as a focused translational engine, combining academic research with hands-on development capabilities, milestone-driven execution, and commercialization awareness.
This structure enables the advancement of complex research programs that require long-term commitment, interdisciplinary integration, and a clear path from concept to application. The framework supports risk-taking, bold scientific directions, and the pursuit of breakthrough innovations that extend beyond incremental research.
Research and Innovation Domains
Research activity within NIBN spans a range of strategic domains aligned with the scientific strengths of Ben-Gurion University of the Negev and global biotechnological needs.
Biopharmaceutical Development
Research programs addressing cancer, metabolic disorders, immune-mediated diseases, and complex biological conditions, with an emphasis on identifying novel therapeutic targets and development strategies.
Translational and Applied Biotechnology
Projects focused on converting fundamental discoveries into practical biotechnological applications, including therapeutic platforms, diagnostics, and enabling technologies.
Human Genetic Disorders
Investigations into inherited diseases and genetic mechanisms, supporting the development of innovative diagnostic approaches and intervention strategies.
Infectious and Neurodegenerative Diseases
Research exploring the biology of infectious agents and degenerative processes, contributing to improved understanding and the identification of new therapeutic pathways.
AgBio and Life Sciences Applications
Biotechnological research with relevance to agriculture, sustainability, and biological systems, supporting innovation in food systems and environmental applications.
Together, these domains form an integrated, interdisciplinary platform that connects life sciences, chemistry, engineering, and data-driven research approaches around shared development challenges.
Infrastructure and Capabilities
NIBN operates within an advanced research environment that integrates laboratory infrastructure, scientific expertise, and development-oriented support.
The framework provides access to:
State-of-the-art laboratory facilities and core research infrastructure
Multidisciplinary scientific expertise across life sciences, chemistry, engineering, and related fields
Project-focused development support enabling structured progression from concept to validation
Guidance in intellectual property strategy, technology positioning, and development planning
This combination of capabilities supports the advancement of complex research programs and enables efficient movement from early discovery stages toward more mature development phases.
Translational Pathways and Development Approach
A central element of NIBN’s structure is its focus on translational execution.
Research activity is organized around clear development logic, including feasibility assessment, proof-of-concept validation, and definition of development milestones. Projects are evaluated and advanced based on their scientific merit, technological potential, and relevance to real-world needs.
The framework connects scientific teams with development-oriented professionals, enabling hands-on problem solving, rapid iteration, and cross-disciplinary execution. This approach supports the maturation of early-stage ideas into structured development programs with defined technological direction.
Scientific, Technological and Commercial Impact
The activities carried out within NIBN have generated a substantial pipeline of scientific, technological, and commercial outcomes.
These include:
High-impact publications in leading peer-reviewed scientific journals
The development of extensive intellectual property portfolios and patent families based on BGU-originated research
Licensing of innovative technologies to industry partners and biotechnology companies
The establishment of startup ventures and development programs based on academic discoveries
Multiple research programs originating within NIBN progressed beyond early discovery stages into advanced development and commercialization processes, reflecting the institute’s role as a driver of translational research and applied innovation.
Collaboration and Interdisciplinary Execution
NIBN fosters close collaboration between researchers, clinicians, engineers, and development-oriented professionals across Ben-Gurion University of the Negev.
The framework actively connects diverse disciplines around concrete scientific and technological challenges, enabling rapid iteration, problem solving, and hands-on execution. This environment supports the integration of complementary expertise and promotes the development of solutions that extend beyond the capabilities of any single discipline.
By breaking down traditional academic silos, NIBN enables the formation of agile, cross-functional teams focused on advancing complex research programs toward application.
Integration within BGN and Ben-Gurion University of the Negev
The institute is integrated within Ben-Gurion University of the Negev’s research landscape and aligned with BGN’s mission to promote applied research, commercialization, and industry collaboration.
The framework constitutes a central source of biotechnology-originated technologies within BGN’s portfolio, supporting the university’s commercialization activities in the life sciences domain. Through this integration, discoveries originating from academic research are supported by structured pathways toward development, validation, and engagement with industry and global partners.
This alignment strengthens the university’s capacity to translate scientific excellence into technologies and solutions with real-world relevance.
Positioning within the Biotechnology Landscape
NIBN represents a focused approach to integrating academic research with development-oriented execution in the field of biotechnology. By combining multidisciplinary science, advanced infrastructure, and commercialization awareness, the institute contributes to positioning Ben-Gurion University of the Negev as a center for impactful biotechnological innovation.
The framework reflects a commitment to advancing research that addresses global challenges in health, medicine, agriculture, and the life sciences, while maintaining strong connections to application and industry needs.
Contact person
